QuidelOrtho (QDEL) stock hit day 8 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -20% return. The company has lost about $339 Mil in value over the last 8 days, with its current market capitalization at about $1.7 Bil. The stock remains 43.2% below its value at the end of 2024. This compares with year-to-date returns of 7.2% for the S&P 500.
Comparing QDEL Stock Returns With The S&P 500
The following table summarizes the return for QDEL stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | QDEL | S&P 500 |
|---|---|---|
| 1D | -0.6% | 0.1% |
| 8D (Current Streak) | -19.9% | 0.7% |
| 1M (21D) | -10.7% | 5.4% |
| 3M (63D) | 0.5% | 19.4% |
| YTD 2025 | -43.2% | 7.2% |
| 2024 | -39.6% | 23.3% |
| 2023 | -14.0% | 24.2% |
| 2022 | -36.5% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 80 S&P constituents with 3 days or more of consecutive gains and 30 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 27 | 23 |
| 4D | 48 | 0 |
| 5D | 0 | 3 |
| 6D | 3 | 0 |
| 7D or more | 2 | 4 |
| Total >=3 D | 80 | 30 |
Key Financials for QuidelOrtho (QDEL)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $3.0 Bil | $2.8 Bil |
| Operating Income | $257.0 Mil | $45.8 Mil |
| Net Income | $-10.1 Mil | $-2.1 Bil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $707.8 Mil | $692.8 Mil |
| Operating Income | $15.2 Mil | $48.7 Mil |
| Net Income | $-178.4 Mil | $-12.7 Mil |
The losing streak QDEL stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
